Inspire Investing, LLC Theravance Biopharma, Inc. Transaction History

Inspire Investing, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 30, 2021	SELL	$16.57 - $21.08 $194,167 - $247,015	-11,718 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$14.89 - $20.16 $174,481 - $236,234	11,718 New	11,718 $208,000
Q3 2020 Nov 16, 2020	SELL	$14.79 - $22.49 $143,048 - $217,523	-9,672 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$20.64 - $30.69 $14,654 - $21,789	710 Added 7.92%	9,672 $203,000
Q1 2020 May 08, 2020	BUY	$17.84 - $31.21 $159,882 - $279,704	8,962 New	8,962 $207,000
Q4 2019 Jan 24, 2020	SELL	$16.12 - $25.89 $179,689 - $288,595	-11,147 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$16.51 - $23.78 $15,552 - $22,400	942 Added 9.23%	11,147 $217,000
Q2 2019 Jul 16, 2019	BUY	$15.6 - $25.15 $159,198 - $256,655	10,205 New	10,205 $167,000
Q1 2018 Apr 13, 2018	SELL	$23.37 - $29.71 $47,043 - $59,806	-2,013 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$25.82 - $35.66 $51,975 - $71,783	2,013	2,013 $56,000

129

46.5M

600

300

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $622M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.